All Stories

  1. Activation of the pro-resolving receptors Fpr2/3 attenuate lipopolysaccharide-induced inflammatory microglial activation
  2. Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3
  3. Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier
  4. Analysis of circulating protein aggregates reveals pathological hallmarks of amyotrophic lateral sclerosis
  5. Reversal of β-amyloid induced microglial toxicity in vitro by activation of Fpr2/3
  6. Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation
  7. Modeling Cardiac Dysfunction Following Traumatic Hemorrhage Injury: Impact on Myocardial Integrity
  8. Desmoglein-3 acts as a pro-survival protein by suppressing reactive oxygen species and doming whilst augmenting the tight junctions in MDCK cells
  9. Estrogen Promotes Pro-resolving Microglial Behavior and Phagocytic Cell Clearance Through the Actions of Annexin A1
  10. Estrogen promotes pro-resolving microglial behaviour and phagocytic cell clearance through the actions of annexin A1:
  11. Activin subfamily peptides predict chronological age in humans
  12. Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
  13. A chemical produced by gut bacteria can help protect the blood–brain barrier
  14. The restorative role of annexin A1 at the blood–brain barrier
  15. Counteractive effects of antenatal glucocorticoid treatment on D1 receptor modulation of spatial working memory
  16. Estrogen protects the blood–brain barrier from inflammation-induced disruption and increased lymphocyte trafficking
  17. Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation
  18. Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment
  19. Astroglial Plasticity Is Implicated in Hippocampal Remodelling in Adult Rats Exposed to Antenatal Dexamethasone
  20. Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
  21. Sex-dependent diversity in ventral tegmental dopaminergic neurons and developmental programing: A molecular, cellular and behavioral analysis
  22. Identification of a Novel Recycling Sequence in the C-tail of FPR2/ALX Receptor
  23. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
  24. Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses
  25. Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23
  26. Antenatal Glucocorticoid Treatment Induces Adaptations in Adult Midbrain Dopamine Neurons, which Underpin Sexually Dimorphic Behavioral Resilience
  27. Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity
  28. Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
  29. Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications
  30. Annexin A1 N-Terminal Derived Peptide Ac2-26 Exerts Chemokinetic Effects on Human Neutrophils
  31. Novel Ontogenetic Patterns of Sexual Differentiation in Arcuate Nucleus GHRH Neurons Revealed in GHRH-Enhanced Green Fluorescent Protein Transgenic Mice
  32. Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson?s Disease
  33. Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of Microglia
  34. Anti-allergic drugs and the Annexin-A1 system
  35. Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines
  36. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens
  37. Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization
  38. Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1
  39. Annexin A1 in the brain – undiscovered roles?
  40. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition
  41. The Size and Distribution of Midbrain Dopaminergic Populations are Permanently Altered by Perinatal Glucocorticoid Exposure in a Sex- Region- and Time-Specific Manner
  42. Perinatal Glucocorticoid Treatment Disrupts the Hypothalamo-Lactotroph Axis in Adult Female, But Not Male, Rats
  43. Altered Mesencephalic Dopaminergic Populations in Adulthood as a Consequence of Brief Perinatal Glucocorticoid Exposure
  44. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease
  45. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females